I was the first surgeon in the state to offer and perform
radiofrequency ablation for a spinal tumor.
This is an important additional tool in the care of oncology
patients with metastatic disease.
I then served as a principal investigator for an IRB-approved,
prospective, randomized, controlled trial utilizing this new
technology at Beaumont. I
recently published my case series regarding the improved outcomes
associated with using this technology for the treatment of breast
cancer patients with spine metastases (Ragheb A, 2022).